<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9604">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05694559</url>
  </required_header>
  <id_info>
    <org_study_id>2022-0328</org_study_id>
    <secondary_id>NCI-2023-00252</secondary_id>
    <nct_id>NCT05694559</nct_id>
  </id_info>
  <brief_title>Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics</brief_title>
  <official_title>Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To identify Black individuals who are eligible for genetic testing through trusted community&#xD;
      organizations, and to connect Black individuals and their families to genetic testing and&#xD;
      counseling so that they can know their cancer risk and how to decrease it.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Objectives:&#xD;
&#xD;
        -  To identify 300 Black families, at least one individual per family, eligible for genetic&#xD;
           testing using our validated simple genetic risk screening tool (GRST) 1, via&#xD;
           collaboration with trusted community organizations. For individuals eligible for genetic&#xD;
           testing, we will counsel them about genetic testing, including reviewing GRST results,&#xD;
           explaining why they are eligible for genetic testing as part of standard-of-care,&#xD;
           explaining what this entails, offering on-site or remote genetic testing, and explaining&#xD;
           that they will be connected to a genetic counselor if they have a pathogenic mutation&#xD;
           (PV) of a variant of unknown significance (VUS), including resources for family cascade&#xD;
           genetic testing.&#xD;
&#xD;
        -  To provide genetic testing to 150 Black individuals and families and provide genetic&#xD;
           counseling and risk reduction resources to individuals with a PV or VUS, including&#xD;
           cascade genetic testing for their family members.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 23, 2022</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>genetic risk screening tool (GRST) questionnaire</measure>
    <time_frame>through study completion; an average of 1 year.</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Genetic Testing and Counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be given a saliva collection kit to collect a saliva sample for hereditary cancer and genetic testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Screening Form</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will complete a screening form to assess your risk of hereditary breast and colorectal cancers. You will be asked to provide your:&#xD;
Name and contact information (including your address, phone number, and email)&#xD;
Demographic information (including your age, race, and ethnicity)&#xD;
Health insurance status&#xD;
Annual household income&#xD;
Personal and family history of cancer, including diagnosis and age at diagnosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Genetic Testing and Counseling</intervention_name>
    <description>Participants will complete testing</description>
    <arm_group_label>Genetic Testing and Counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Screening Form</intervention_name>
    <description>Participants will complete forms with demographics and history</description>
    <arm_group_label>Screening Form</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any participant over 18 years old who self-identifies as Black or African-American and&#xD;
             signs an informed consent form, also referred to as the 'Permission to Contact' form,&#xD;
             to be part of our study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Banu Arun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MD Anderson Cancer Cneter</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Banu Arun, MD</last_name>
    <phone>713-792-2817</phone>
    <email>barun@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Banu Arun, MD</last_name>
      <phone>713-792-2817</phone>
      <email>barun@mdanderson.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>MD Anderson Cancer Center</description>
  </link>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>January 12, 2023</study_first_submitted>
  <study_first_submitted_qc>January 20, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2023</study_first_posted>
  <last_update_submitted>January 20, 2023</last_update_submitted>
  <last_update_submitted_qc>January 20, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

